This article summarized the latest R&D progress of Tesofensine, the Mechanism of Action for Tesofensine, and the drug target R&D trends for Tesofensine.

Drug Farm, currently in the clinical phase, has shared the news of the first participant in the Phase 1 clinical experiment, testing DF-003, receiving their initial dosage.

This article summarized the latest R&D progress of Tenecteplase, the Mechanism of Action for Tenecteplase, and the drug target R&D trends for Tenecteplase.

Monoamine oxidase-B (MAO-B) is an enzyme found in the human body that plays a crucial role in the metabolism of neurotransmitters such as dopamine.

This article summarized the latest R&D progress of Sulfanilamide, the Mechanism of Action for Sulfanilamide, and the drug target R&D trends for Sulfanilamide.

The study on Atrial Fibrillation using Abelacimab was prematurely ended by the Data Monitoring Committee due to a massive decrease in bleeding compared to a DOAC.

This article summarized the latest R&D progress of Sulfadiazine, the Mechanism of Action for Sulfadiazine, and the drug target R&D trends for Sulfadiazine.

Interleukin-1 receptor-associated kinases (IRAKs) were initially identified as serine/threonine kinases that can bind to the interleukin-1 receptor (IL-1R) upon induction by the pro-inflammatory cytokine interleukin-1 (IL-1).

This article summarized the latest R&D progress of Cefpodoxime proxetil, the Mechanism of Action for Cefpodoxime proxetil, and the drug target R&D trends for Cefpodoxime proxetil.

LinKinVax and Gustave Roussy have reported that Gustave Roussy is treating the initial participant in a Phase I/IIa clinical trial using CD40HVac.

This article summarized the latest R&D progress of Sulfacetamide sodium, the Mechanism of Action for Sulfacetamide sodium, and the drug target R&D trends for Sulfacetamide sodium.

IL-17, or Interleukin-17, is a cytokine that plays a crucial role in the human body's immune response.